Role of neurohormonal modulators in heart failure with relatively preserved systolic function
- PMID: 17386836
- DOI: 10.1016/j.hfc.2004.10.003
Role of neurohormonal modulators in heart failure with relatively preserved systolic function
Similar articles
-
Role of neurohormonal modulators in heart failure with relatively preserved systolic function.Cardiol Clin. 2008 Feb;26(1):23-40, vi. doi: 10.1016/j.ccl.2007.11.001. Cardiol Clin. 2008. PMID: 18312903 Review.
-
Pharmacogenomics for neurohormonal intervention in heart failure.Heart Fail Clin. 2005 Apr;1(1):141-50. doi: 10.1016/j.hfc.2004.10.001. Epub 2005 Jan 8. Heart Fail Clin. 2005. PMID: 17386840 Review. No abstract available.
-
Heart failure: recent advances in prevention and treatment.Rev Cardiovasc Med. 2000 Summer;1(1):25-33, 54. Rev Cardiovasc Med. 2000. PMID: 12457149 Review.
-
[Treatment of heart failure and preserved systolic function].Lakartidningen. 2007 Aug 22-28;104(34):2348-50. Lakartidningen. 2007. PMID: 17907560 Swedish. No abstract available.
-
Heart failure.Clin Evid. 2003 Jun;(9):95-118. Clin Evid. 2003. Update in: Clin Evid. 2004 Jun;(11):122-48. PMID: 12967355 Updated. Review. No abstract available.
Cited by
-
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2021 May 22;5:CD012721. doi: 10.1002/14651858.CD012721.pub3. PMID: 29952095 Free PMC article. Updated.
-
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.Cochrane Database Syst Rev. 2021 May 22;5(5):CD012721. doi: 10.1002/14651858.CD012721.pub3. Cochrane Database Syst Rev. 2021. PMID: 34022072 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical